{"name":"Anterios Inc.","slug":"anterios-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ANT-1207","genericName":"ANT-1207","slug":"ant-1207","indication":"Type 2 diabetes","status":"phase_2"},{"name":"ANT-1401","genericName":"ANT-1401","slug":"ant-1401","indication":"Type 2 diabetes","status":"phase_2"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"ANT-1403","genericName":"ANT-1403","slug":"ant-1403","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"ANT-1207","genericName":"ANT-1207","slug":"ant-1207","phase":"phase_2","mechanism":"ANT-1207 is a small molecule inhibitor of the sodium-glucose cotransporter 2 (SGLT2).","indications":["Type 2 diabetes"],"catalyst":""},{"name":"ANT-1401","genericName":"ANT-1401","slug":"ant-1401","phase":"phase_2","mechanism":"ANT-1401 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"ANT-1403","genericName":"ANT-1403","slug":"ant-1403","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPMjctYmpoLTdoZG5Zc3BoV0w3YVZfS2pwN0lOOWNnR0ZZTzV5ekJRaGdKYVdpZXhNQ3RZb05QVG9rU3NNRXl0WEY4YWF6TU5mQmctQ3llazZOTElrN0RGZDZhT1lpVWtLRUttVmxPM1FJR3ViOG52ajVSZTBwZ3RFcV9WUUFXOEJ1QXliTnllbGxHOEE?oc=5","date":"2024-06-21","type":"pipeline","source":"SEC.gov","summary":"abbv-20221231xex21.htm - SEC.gov","headline":"abbv-20221231xex21.htm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQX1VOWmUxalV4R3R0aVBVazdlMG0tX1c4amJFYnNOcTlBN0pudDJNTS1mRGNFdVdKWDNsbFlpY3FxMHBoeE9YR0F1SjZDenBLMDRTVFFDaFN2aGpiRGhSaXhHc1d6R0lPbTROSDdURGxfc2VvRnBHODVrR05RRWxUc3QtSTl1dzF2a0NWRDNGdFVjTWM?oc=5","date":"2018-12-15","type":"pipeline","source":"UMass Lowell","summary":"Sale of UMass Lowell-Developed Technology Brings In $3.8M - UMass Lowell","headline":"Sale of UMass Lowell-Developed Technology Brings In $3.8M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxQQVloQ0pRQzFtVGhiQVNvOUJ0TGxVRDV6Tjk3em0wVTdyeFB5SThTQlhuOEl6SFhuUlc0cDJ0czFoVG1TNER3cFhYVDExOEVZdDNwSm85V05Gb3Z6Umd6M3ZCbXl6Qk13LVN6NU1iN2NBV21KaXl6cF9jVnk3Vk1zaDNiWnotOHhXSUtoemREbVBoVGpMR29Fam9YaDUxYkF4VmZlYg?oc=5","date":"2016-04-21","type":"pipeline","source":"Fall River Herald News","summary":"Former UMass Dartmouth professor opening biotech lab in Fall River - Fall River Herald News","headline":"Former UMass Dartmouth professor opening biotech lab in Fall River","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOWlhNMTNPSDBzT1lPVWs0Y3d0YXcwX3Znalc5VG5ub0hTRXhsRHV3YWFRWEpGNWJnNnR2ckRjVjF2eU1HYWRPa0loQkJRcjYySEVsbXBtWndXb0J0N09GUHQwR3lVQzRiaGJFWXcwai1lbmEyNWZCZWk4Zm9DSE5fN1g2UzlDZnZyREloZjM0U2JHdTR5SUM5c2lSdlRSQVZEMkpKenlCWkNlaHpkZnZ4WHQ2bktuaFpP?oc=5","date":"2016-01-12","type":"deal","source":"BioPharma Dive","summary":"Allergan acquires Anterios to enhance neurotoxin delivery, bolsters Botox portfolio - BioPharma Dive","headline":"Allergan acquires Anterios to enhance neurotoxin delivery, bolsters Botox portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPNGtOeFJZVW1WV29QZnZOU2pjZ3VOWTNnazR1OFI2T054VHJaZVlYaHd4MG9XSUxBWEFpUl9GMmV5TUhvZVVxVzBySDljbDdUWlVMMHBHZXZBRmE2OVl6STY4b2VnVDFycGt5Qmg1Zk1Oc1FEcDhVV0NvTi1xbDJqdTJFMER5aFhHNHhZV0R1R1gxWl9rS2xxcThmcG5fZ1R4LXQxTWNydERnSjA2YUpKY2k0NlhnVi14dmVHejlpN3lWNFVoV0dkOUNPR3VWS2xWVUJsNXFpRWctcjdmbExYZ3RGbDJyTVJDakU4S2R2ektUQWphR3c?oc=5","date":"2016-01-07","type":"deal","source":"PR Newswire","summary":"Allergan Acquires Medical Dermatology and Aesthetic Medicine Company Anterios to Expand Neurotoxin Pipeline - PR Newswire","headline":"Allergan Acquires Medical Dermatology and Aesthetic Medicine Company Anterios to Expand Neurotoxin Pipeline","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":3},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}